Fulcrum Therapeutics, Inc. · NASDAQ:FULC

Adage Capital Management, L.P.'s stake in Fulcrum Therapeutics, Inc. fell to 4.50% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 13, 2025

Adage Capital Management, L.P.'s stake in Fulcrum Therapeutics, Inc. fell to 4.50%, 2,432,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).

Stake
4.50%
Shares
2,432,000
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Adage Capital Management, L.P.4.50%2,432,000
Robert Atchinson4.50%2,432,000
Phillip Gross4.50%2,432,000

Source

View original at SEC

Related